296 related articles for article (PubMed ID: 29666227)
1. Anti-HIV-1 B cell responses are dependent on B cell precursor frequency and antigen-binding affinity.
Dosenovic P; Kara EE; Pettersson AK; McGuire AT; Gray M; Hartweger H; Thientosapol ES; Stamatatos L; Nussenzweig MC
Proc Natl Acad Sci U S A; 2018 May; 115(18):4743-4748. PubMed ID: 29666227
[TBL] [Abstract][Full Text] [Related]
2. B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.
Huang D; Abbott RK; Havenar-Daughton C; Skog PD; Al-Kolla R; Groschel B; Blane TR; Menis S; Tran JT; Thinnes TC; Volpi SA; Liguori A; Schiffner T; Villegas SM; Kalyuzhniy O; Pintea M; Voss JE; Phelps N; Tingle R; Rodriguez AR; Martin G; Kupryianov S; deCamp A; Schief WR; Nemazee D; Crotty S
Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22920-22931. PubMed ID: 32873644
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.
Jardine JG; Kulp DW; Havenar-Daughton C; Sarkar A; Briney B; Sok D; Sesterhenn F; Ereño-Orbea J; Kalyuzhniy O; Deresa I; Hu X; Spencer S; Jones M; Georgeson E; Adachi Y; Kubitz M; deCamp AC; Julien JP; Wilson IA; Burton DR; Crotty S; Schief WR
Science; 2016 Mar; 351(6280):1458-63. PubMed ID: 27013733
[TBL] [Abstract][Full Text] [Related]
4. Anti-HIV B Cell lines as candidate vaccine biosensors.
Ota T; Doyle-Cooper C; Cooper AB; Huber M; Falkowska E; Doores KJ; Hangartner L; Le K; Sok D; Jardine J; Lifson J; Wu X; Mascola JR; Poignard P; Binley JM; Chakrabarti BK; Schief WR; Wyatt RT; Burton DR; Nemazee D
J Immunol; 2012 Nov; 189(10):4816-24. PubMed ID: 23066156
[TBL] [Abstract][Full Text] [Related]
5. Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies.
Verkoczy L; Alt FW; Tian M
Immunol Rev; 2017 Jan; 275(1):89-107. PubMed ID: 28133799
[TBL] [Abstract][Full Text] [Related]
6. Affinity gaps among B cells in germinal centers drive the selection of MPER precursors.
Ray R; Schiffner T; Wang X; Yan Y; Rantalainen K; Lee CD; Parikh S; Reyes RA; Dale GA; Lin YC; Pecetta S; Giguere S; Swanson O; Kratochvil S; Melzi E; Phung I; Madungwe L; Kalyuzhniy O; Warner J; Weldon SR; Tingle R; Lamperti E; Kirsch KH; Phelps N; Georgeson E; Adachi Y; Kubitz M; Nair U; Crotty S; Wilson IA; Schief WR; Batista FD
Nat Immunol; 2024 Jun; 25(6):1083-1096. PubMed ID: 38816616
[TBL] [Abstract][Full Text] [Related]
7. Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice.
Escolano A; Steichen JM; Dosenovic P; Kulp DW; Golijanin J; Sok D; Freund NT; Gitlin AD; Oliveira T; Araki T; Lowe S; Chen ST; Heinemann J; Yao KH; Georgeson E; Saye-Francisco KL; Gazumyan A; Adachi Y; Kubitz M; Burton DR; Schief WR; Nussenzweig MC
Cell; 2016 Sep; 166(6):1445-1458.e12. PubMed ID: 27610569
[TBL] [Abstract][Full Text] [Related]
8. Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice.
McGuire AT; Gray MD; Dosenovic P; Gitlin AD; Freund NT; Petersen J; Correnti C; Johnsen W; Kegel R; Stuart AB; Glenn J; Seaman MS; Schief WR; Strong RK; Nussenzweig MC; Stamatatos L
Nat Commun; 2016 Feb; 7():10618. PubMed ID: 26907590
[TBL] [Abstract][Full Text] [Related]
9. Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires.
Tian M; Cheng C; Chen X; Duan H; Cheng HL; Dao M; Sheng Z; Kimble M; Wang L; Lin S; Schmidt SD; Du Z; Joyce MG; Chen Y; DeKosky BJ; Chen Y; Normandin E; Cantor E; Chen RE; Doria-Rose NA; Zhang Y; Shi W; Kong WP; Choe M; Henry AR; Laboune F; Georgiev IS; Huang PY; Jain S; McGuire AT; Georgeson E; Menis S; Douek DC; Schief WR; Stamatatos L; Kwong PD; Shapiro L; Haynes BF; Mascola JR; Alt FW
Cell; 2016 Sep; 166(6):1471-1484.e18. PubMed ID: 27610571
[TBL] [Abstract][Full Text] [Related]
10. Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice.
Sok D; Briney B; Jardine JG; Kulp DW; Menis S; Pauthner M; Wood A; Lee EC; Le KM; Jones M; Ramos A; Kalyuzhniy O; Adachi Y; Kubitz M; MacPherson S; Bradley A; Friedrich GA; Schief WR; Burton DR
Science; 2016 Sep; 353(6307):1557-1560. PubMed ID: 27608668
[TBL] [Abstract][Full Text] [Related]
11. Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies.
Hwang JK; Wang C; Du Z; Meyers RM; Kepler TB; Neuberg D; Kwong PD; Mascola JR; Joyce MG; Bonsignori M; Haynes BF; Yeap LS; Alt FW
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):8614-8619. PubMed ID: 28747530
[TBL] [Abstract][Full Text] [Related]
12. Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10.
Doyle-Cooper C; Hudson KE; Cooper AB; Ota T; Skog P; Dawson PE; Zwick MB; Schief WR; Burton DR; Nemazee D
J Immunol; 2013 Sep; 191(6):3186-3191. PubMed ID: 23940276
[TBL] [Abstract][Full Text] [Related]
13. B cell clonal lineage alterations upon recombinant HIV-1 envelope immunization of rhesus macaques.
Yacoob C; Lange MD; Cohen K; Lathia K; Feng J; Glenn J; Carbonetti S; Oliver B; Vigdorovich V; Sather DN; Stamatatos L
PLoS Pathog; 2018 Jun; 14(6):e1007120. PubMed ID: 29933399
[TBL] [Abstract][Full Text] [Related]
14. Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies.
Briney B; Sok D; Jardine JG; Kulp DW; Skog P; Menis S; Jacak R; Kalyuzhniy O; de Val N; Sesterhenn F; Le KM; Ramos A; Jones M; Saye-Francisco KL; Blane TR; Spencer S; Georgeson E; Hu X; Ozorowski G; Adachi Y; Kubitz M; Sarkar A; Wilson IA; Ward AB; Nemazee D; Burton DR; Schief WR
Cell; 2016 Sep; 166(6):1459-1470.e11. PubMed ID: 27610570
[TBL] [Abstract][Full Text] [Related]
15. What Are the Primary Limitations in B-Cell Affinity Maturation, and How Much Affinity Maturation Can We Drive with Vaccination? Breaking through Immunity's Glass Ceiling.
Kelsoe G; Haynes BF
Cold Spring Harb Perspect Biol; 2018 May; 10(5):. PubMed ID: 28630077
[TBL] [Abstract][Full Text] [Related]
16. Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem.
Havenar-Daughton C; Lee JH; Crotty S
Immunol Rev; 2017 Jan; 275(1):49-61. PubMed ID: 28133798
[TBL] [Abstract][Full Text] [Related]
17. HIV Broadly Neutralizing Antibodies: VRC01 and Beyond.
Wu X
Adv Exp Med Biol; 2018; 1075():53-72. PubMed ID: 30030789
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for germline antibody recognition of HIV-1 immunogens.
Scharf L; West AP; Sievers SA; Chen C; Jiang S; Gao H; Gray MD; McGuire AT; Scheid JF; Nussenzweig MC; Stamatatos L; Bjorkman PJ
Elife; 2016 Mar; 5():. PubMed ID: 26997349
[TBL] [Abstract][Full Text] [Related]
19. Strategies for a multi-stage neutralizing antibody-based HIV vaccine.
Andrabi R; Bhiman JN; Burton DR
Curr Opin Immunol; 2018 Aug; 53():143-151. PubMed ID: 29775847
[TBL] [Abstract][Full Text] [Related]
20. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
